These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2780585)

  • 21. Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart.
    Chi L; Park JL; Friedrichs GS; Banglawala YA; Perez MA; Tanhehco EJ; Lucchesi BR
    Br J Pharmacol; 1996 Mar; 117(6):1261-9. PubMed ID: 8882624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The mechanism of membranotropic action of 1-ethoxysilatrane].
    Rasulov MM; Kuznetsov IG; Belousov AA; Voronkov MG
    Dokl Akad Nauk SSSR; 1989; 306(6):1479-82. PubMed ID: 2553369
    [No Abstract]   [Full Text] [Related]  

  • 23. Tedisamil inhibits the delayed rectifier K+ current in single smooth muscle cells of the guinea-pig portal vein.
    Pfründer D; Kreye VA
    Pflugers Arch; 1992 May; 421(1):22-5. PubMed ID: 1630881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cellular electrophysiological effects of tedisamil in human atrial and ventricular fibers.
    Németh M; Virág L; Hála O; Varró A; Kovács G; Thormählen D; Papp JG
    Cardiovasc Res; 1996 Feb; 31(2):246-8. PubMed ID: 8730401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanism of membranotropic effect of methylethyl(silatrane-1-yl methyl) sulfonium iodide].
    Kuznetsov IG; Rasulov MM; Sorokin MS; Suslova SK; Voronkov MG
    Dokl Akad Nauk SSSR; 1988; 301(5):1235-7. PubMed ID: 2852585
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiac and hemodynamic effects of the selective bradycardic agent KC 8857 during exercise-induced myocardial ischemia.
    Grohs JG; Fischer G; Raberger G
    Eur J Pharmacol; 1989 Feb; 161(1):53-60. PubMed ID: 2721548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of the long-acting analgesics 3-(beta-phenylethyl)-9 beta-methoxy-9 alpha-(m-hydroxyphenyl)-3-azabicycles [3,3,1]-nonane (P-7521) on opiate receptor binding in vitro].
    Zhou DH; Ge BL; Xu XJ; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1988 Nov; 9(6):511-5. PubMed ID: 2855686
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of tedisamil on cardiovascular tissues isolated from normo- and hypertensive rats.
    Doggrell SA; Nand V
    J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):261-72. PubMed ID: 11584333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical defibrillation in acute myocardial ischaemia: a hypothesis.
    Curtis MJ
    J Basic Clin Physiol Pharmacol; 1994; 5(1):1-17. PubMed ID: 8736067
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anticoagulant and antiatherosclerotic effects of 1-ethoxysilatrane].
    Rasulov MM; Kuznetsov IG; Velikaia MV; Bartkova LK; Voronkov MG
    Dokl Akad Nauk SSSR; 1990; 310(5):1256-9. PubMed ID: 2354655
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of haemorrhage on wound healing and its possible modification by 1-ethoxysilatrane.
    Taylor DE; Cooper GJ; Evans VA; Kenward CE; Lawston IW; Penhallow JE; Whamond JS
    J R Coll Surg Edinb; 1986 Feb; 31(1):13-7. PubMed ID: 2940364
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of isopropoxysilatrane and isopropoxygermatrane on connective tissue proliferative and reparative function].
    Mansurova LA; Voronkov MG; Slutskiĭ LI; Bumagina TP; Gar TK
    Dokl Akad Nauk SSSR; 1982; 262(6):1505-6. PubMed ID: 7067613
    [No Abstract]   [Full Text] [Related]  

  • 33. Mixed blockade of K+ and Na+ currents in rat ventricular myocytes by the tedisamil analogue, KC8851.
    McLarnon JG; Xu R
    Eur J Pharmacol; 1997 Nov; 339(2-3):279-88. PubMed ID: 9473146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sparteine and tedisamil inhibit chloride channels in pulmonary epithelial cells isolated from patients with cystic fibrosis].
    Lacinová L
    Bratisl Lek Listy; 1992 Aug; 93(8):411-4. PubMed ID: 1281441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of BRB-I-28, a novel antiarrhythmic agent, and its derivatives on cardiac Na+,K(+)-ATPase, Mg(2+)-ATPase activities and contractile force.
    Chen CL; Sangiah S; Patterson E; Berlin KD; Garrison GL; Dunn W; Nan Y; Scherlag BJ; Lazzara R
    Res Commun Chem Pathol Pharmacol; 1992 Oct; 78(1):3-16. PubMed ID: 1334277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further observations on the antispasmodic activity of rociverine.
    Coruzzi G; Adami M; Poli E; Bertaccini G
    Farmaco Prat; 1982 Apr; 37(4):109-15. PubMed ID: 7084440
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiarrhythmic drug therapy of atrial fibrillation: focus on new agents.
    Dorian P
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8 Suppl 1():S27-31. PubMed ID: 12746749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of tedisamil on the initiation and maintenance of ventricular fibrillation: chemical defibrillation by Ito blockade?
    Tsuchihashi K; Curtis MJ
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):445-56. PubMed ID: 1720845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of potent analgesic 3-(beta-phenylethyl)-9 beta-methoxy-9 alpha-(m-hydroxyphenyl)-3-azabicyclo [3,3,1]-nonane (p-5721) on electroencephalography in rabbits].
    Zhao GM; Zhou J; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):300-3. PubMed ID: 3195338
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparisons of effects of Hoe-498 and enalapril in isolated guinea pig hearts and rat myocardium].
    Xiang JZ; Schölkens BA; Linz W; Unger T; Ganten D; Lang RE
    Zhongguo Yao Li Xue Bao; 1985 Jun; 6(2):96-9. PubMed ID: 3002124
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.